Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Melanie Joy

Concepts (391)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Glomerulonephritis
8
2021
64
3.660
 Why?
Cyclophosphamide
5
2021
234
2.540
 Why?
Lupus Nephritis
5
2021
56
2.540
 Why?
Cisplatin
8
2022
277
2.480
 Why?
Kidney
15
2022
1191
2.470
 Why?
Acute Kidney Injury
11
2022
600
2.240
 Why?
Mycophenolic Acid
7
2016
81
2.120
 Why?
Glomerulosclerosis, Focal Segmental
6
2015
41
2.090
 Why?
Kidney Diseases
9
2016
402
1.970
 Why?
Organic Anion Transporters
2
2021
27
1.560
 Why?
Immunosuppressive Agents
5
2021
678
1.470
 Why?
Pharmaceutical Preparations
4
2021
174
1.390
 Why?
Kidney Failure, Chronic
13
2009
499
1.350
 Why?
Autoimmune Diseases
4
2021
410
1.340
 Why?
Membrane Transport Proteins
3
2017
152
1.290
 Why?
Enzyme Inhibitors
4
2010
931
1.170
 Why?
Vitamin D
3
2022
345
1.160
 Why?
Antineoplastic Agents
6
2022
2032
1.150
 Why?
Cholecalciferol
2
2022
49
1.140
 Why?
Vasculitis
6
2012
85
1.100
 Why?
Glucuronides
4
2015
21
1.050
 Why?
Antibodies, Antineutrophil Cytoplasmic
5
2010
32
0.910
 Why?
Aryl Hydrocarbon Hydroxylases
3
2012
51
0.900
 Why?
Uremia
1
2021
19
0.880
 Why?
Proteinuria
6
2017
104
0.870
 Why?
Adalimumab
4
2015
41
0.860
 Why?
Creatinine
11
2021
453
0.850
 Why?
Renal Dialysis
11
2007
362
0.830
 Why?
Glomerular Filtration Rate
6
2018
587
0.830
 Why?
Rituximab
2
2018
167
0.820
 Why?
Anti-Inflammatory Agents
3
2013
458
0.770
 Why?
Calcineurin Inhibitors
3
2016
63
0.770
 Why?
Glomerulonephritis, Membranous
1
2018
5
0.750
 Why?
Membranes, Artificial
3
2018
75
0.750
 Why?
Hemoperfusion
1
2018
5
0.730
 Why?
Lanthanum
4
2006
12
0.720
 Why?
Hyperphosphatemia
1
2018
16
0.720
 Why?
Glucuronosyltransferase
3
2015
10
0.710
 Why?
Kidney Tubules, Proximal
2
2016
93
0.690
 Why?
Anemia
3
2009
163
0.680
 Why?
Pharmacogenomic Variants
1
2017
33
0.670
 Why?
Simvastatin
1
2017
68
0.660
 Why?
Humans
74
2022
113890
0.660
 Why?
Oleanolic Acid
1
2016
9
0.640
 Why?
Terfenadine
2
2013
2
0.630
 Why?
Hyperparathyroidism, Secondary
3
2007
14
0.630
 Why?
Azathioprine
1
2016
53
0.610
 Why?
Enzymes
1
2016
71
0.590
 Why?
Adult
31
2021
31958
0.570
 Why?
Pharmacogenetics
1
2016
152
0.560
 Why?
Renal Insufficiency, Chronic
2
2013
493
0.560
 Why?
Brain Diseases
1
2016
160
0.550
 Why?
Middle Aged
29
2021
28776
0.540
 Why?
Oxidoreductases, N-Demethylating
2
2012
11
0.540
 Why?
Flurbiprofen
1
2013
4
0.530
 Why?
Male
40
2022
60623
0.530
 Why?
Liver Diseases
1
2016
273
0.520
 Why?
Biomarkers
8
2022
3468
0.520
 Why?
Metabolic Clearance Rate
7
2018
134
0.520
 Why?
Pharmacokinetics
2
2012
32
0.510
 Why?
Female
38
2021
62822
0.500
 Why?
Hypothyroidism
1
2013
72
0.490
 Why?
Leukocytes
1
2014
292
0.480
 Why?
Multidrug Resistance-Associated Proteins
3
2017
38
0.480
 Why?
Half-Life
5
2018
171
0.470
 Why?
Serum Albumin
5
2012
159
0.470
 Why?
Metabolic Networks and Pathways
1
2013
175
0.470
 Why?
Cytochrome P-450 Enzyme System
2
2016
129
0.460
 Why?
Antibodies, Monoclonal, Humanized
3
2013
647
0.460
 Why?
Heptanoic Acids
3
2011
69
0.440
 Why?
Patient Care Team
2
2007
533
0.440
 Why?
Losartan
2
2011
14
0.420
 Why?
Naphthalenes
3
2007
59
0.420
 Why?
Tacrolimus
2
2016
146
0.410
 Why?
Nephrology
2
2007
31
0.410
 Why?
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
1
2010
15
0.410
 Why?
Aged
18
2018
20127
0.400
 Why?
Bupropion
1
2010
38
0.400
 Why?
RNA, Messenger
3
2016
2817
0.400
 Why?
Pyrroles
3
2011
202
0.400
 Why?
Phosphates
2
2018
175
0.400
 Why?
Organic Cation Transporter 2
2
2021
12
0.400
 Why?
Epithelial Cells
1
2016
1018
0.400
 Why?
Antidepressive Agents, Second-Generation
1
2010
43
0.400
 Why?
Anticholesteremic Agents
3
2011
136
0.390
 Why?
Kidney Transplantation
3
2009
518
0.390
 Why?
Organic Cation Transport Proteins
2
2021
36
0.390
 Why?
Dose-Response Relationship, Drug
8
2016
2185
0.360
 Why?
Hypercholesterolemia
2
2007
102
0.340
 Why?
Thiazolidinediones
1
2008
158
0.340
 Why?
Milrinone
2
2018
30
0.330
 Why?
Polymorphism, Single Nucleotide
3
2017
1741
0.330
 Why?
Severity of Illness Index
2
2013
2845
0.330
 Why?
Lipoproteins
1
2007
171
0.320
 Why?
Neoplasms
3
2018
2060
0.320
 Why?
Antibodies, Monoclonal
2
2011
1288
0.310
 Why?
Pharmacists
2
2007
251
0.310
 Why?
Biological Transport
4
2021
427
0.310
 Why?
Erythropoietin
2
2007
84
0.310
 Why?
Ambulatory Care
2
2007
459
0.300
 Why?
Area Under Curve
4
2018
322
0.300
 Why?
Vitamins
1
2007
148
0.300
 Why?
Granulomatosis with Polyangiitis
1
2005
37
0.300
 Why?
Glycated Hemoglobin A
2
2002
781
0.290
 Why?
Prodrugs
1
2005
42
0.290
 Why?
Antihypertensive Agents
1
2009
458
0.290
 Why?
NF-E2-Related Factor 2
2
2016
80
0.290
 Why?
Case Management
1
2005
69
0.280
 Why?
Chronic Disease
7
2012
1652
0.280
 Why?
Organ Transplantation
1
2007
157
0.280
 Why?
Cyclosporine
1
2005
181
0.280
 Why?
Aniline Compounds
1
2004
63
0.280
 Why?
Hemofiltration
3
2000
32
0.270
 Why?
Regression Analysis
3
2018
1110
0.270
 Why?
Quality Assurance, Health Care
1
2007
377
0.270
 Why?
Treatment Outcome
10
2013
9100
0.260
 Why?
HEK293 Cells
4
2021
647
0.250
 Why?
Vitamin D3 24-Hydroxylase
1
2022
14
0.240
 Why?
Chromatography, Liquid
3
2021
340
0.240
 Why?
Carcinoma, Renal Cell
2
2015
170
0.230
 Why?
Blood Pressure
1
2009
1728
0.230
 Why?
Cytochrome P-450 CYP2C9
2
2013
16
0.230
 Why?
Cytochrome P-450 CYP2B6
2
2012
11
0.230
 Why?
Genotype
3
2014
1851
0.220
 Why?
Imatinib Mesylate
1
2021
65
0.220
 Why?
Vancomycin
2
2021
60
0.220
 Why?
Biomedical Research
1
2007
585
0.220
 Why?
Antiemetics
1
2021
35
0.220
 Why?
Young Adult
7
2021
10971
0.220
 Why?
Tissue Distribution
2
2013
362
0.220
 Why?
Particle Size
2
2021
384
0.210
 Why?
Models, Biological
2
2021
1812
0.210
 Why?
Cytochrome P-450 CYP3A
2
2013
59
0.210
 Why?
Kidney Neoplasms
2
2015
326
0.200
 Why?
Exosomes
1
2021
79
0.200
 Why?
Administration, Oral
4
2018
795
0.200
 Why?
Mitogen-Activated Protein Kinase Kinases
1
2020
125
0.200
 Why?
Polymorphism, Genetic
2
2016
661
0.200
 Why?
Pilot Projects
4
2018
1412
0.190
 Why?
Age Factors
3
2015
3271
0.190
 Why?
Tricarboxylic Acids
1
2018
12
0.180
 Why?
Off-Label Use
1
2018
44
0.180
 Why?
Hematinics
2
2009
21
0.180
 Why?
Follow-Up Studies
6
2011
4927
0.180
 Why?
Animals
11
2022
34695
0.180
 Why?
Clonazepam
1
1997
7
0.180
 Why?
Kidney Function Tests
3
2017
159
0.180
 Why?
GABA Modulators
1
1997
13
0.180
 Why?
Indican
1
2017
1
0.180
 Why?
Prospective Studies
5
2018
6292
0.170
 Why?
Renal Replacement Therapy
1
1998
63
0.170
 Why?
Quality of Life
1
2009
2197
0.170
 Why?
Glutathione S-Transferase pi
1
2017
9
0.170
 Why?
Adsorption
1
2018
154
0.170
 Why?
Anti-Anxiety Agents
1
1997
51
0.170
 Why?
Restless Legs Syndrome
1
1997
24
0.170
 Why?
Thyroid Diseases
2
2007
38
0.170
 Why?
Infusions, Intravenous
1
2018
405
0.170
 Why?
Parathyroid Hormone
4
2007
117
0.170
 Why?
Osteoporosis
1
2000
195
0.170
 Why?
Child
8
2016
17710
0.170
 Why?
Xenobiotics
1
2017
26
0.160
 Why?
Fructose
1
2018
193
0.160
 Why?
Adolescent
9
2015
18580
0.160
 Why?
Phosphorus
3
2006
95
0.160
 Why?
Cation Transport Proteins
1
2017
116
0.160
 Why?
Subcutaneous Absorption
1
2015
1
0.150
 Why?
Hemoglobins
2
2009
284
0.150
 Why?
Adrenal Cortex Hormones
1
2000
508
0.150
 Why?
Gene Expression Regulation
2
2016
2564
0.150
 Why?
Tumor Necrosis Factor-alpha
2
2013
1241
0.150
 Why?
Drug Interactions
1
2017
405
0.150
 Why?
Hydroxychloroquine
1
2016
58
0.150
 Why?
Injections, Subcutaneous
1
2015
159
0.150
 Why?
Cell Survival
2
2016
1138
0.150
 Why?
Phthalimides
1
2015
1
0.150
 Why?
Darbepoetin alfa
2
2007
5
0.150
 Why?
Blood-Brain Barrier
1
2016
114
0.150
 Why?
Societies, Pharmaceutical
2
2005
28
0.150
 Why?
Proteomics
1
2021
756
0.150
 Why?
Isoquinolines
1
2015
42
0.140
 Why?
Hepatocytes
1
2016
206
0.140
 Why?
Blood Glucose
2
2018
1873
0.140
 Why?
Drug Therapy
1
1995
83
0.140
 Why?
Reactive Oxygen Species
1
2017
548
0.140
 Why?
Cholesterol, LDL
2
2007
309
0.140
 Why?
RNA Isoforms
1
2013
2
0.140
 Why?
C-Reactive Protein
2
2007
347
0.140
 Why?
Tenofovir
1
2016
220
0.130
 Why?
Tandem Mass Spectrometry
2
2021
386
0.130
 Why?
Case-Control Studies
3
2013
3247
0.130
 Why?
Breath Tests
1
2013
92
0.130
 Why?
Protein Kinase Inhibitors
1
2020
852
0.130
 Why?
Critical Care
1
1998
511
0.130
 Why?
Angiotensin II Type 1 Receptor Blockers
2
2011
38
0.120
 Why?
Myocytes, Cardiac
1
2017
495
0.120
 Why?
Complement Activation
1
2015
336
0.120
 Why?
Liver
2
2018
1825
0.120
 Why?
Treatment Failure
1
2013
334
0.120
 Why?
Intracellular Signaling Peptides and Proteins
1
2015
403
0.120
 Why?
Cells, Cultured
2
2021
4287
0.120
 Why?
Alternative Splicing
1
2013
210
0.110
 Why?
Drug Resistance
2
2011
186
0.110
 Why?
Galactose
1
2011
23
0.110
 Why?
Disease Models, Animal
1
2021
3850
0.110
 Why?
Mice
3
2022
15400
0.110
 Why?
Critical Illness
1
2016
579
0.100
 Why?
Cephalosporins
2
2000
24
0.100
 Why?
Drug Administration Schedule
2
2003
806
0.100
 Why?
Stereoisomerism
1
2010
112
0.100
 Why?
Lupus Erythematosus, Systemic
1
2012
255
0.100
 Why?
Inflammation
1
2021
2431
0.100
 Why?
Randomized Controlled Trials as Topic
3
2004
1154
0.100
 Why?
Fetus
1
2013
655
0.100
 Why?
Diabetes Mellitus
1
1998
952
0.100
 Why?
Anti-Allergic Agents
1
2009
51
0.100
 Why?
Calcium
4
2005
1195
0.090
 Why?
Lipocalin-2
2
2020
56
0.090
 Why?
Body Surface Area
1
2008
30
0.090
 Why?
Quality Indicators, Health Care
1
2012
314
0.090
 Why?
Mass Spectrometry
1
2012
703
0.090
 Why?
Anti-Bacterial Agents
1
1998
1365
0.090
 Why?
Diabetes Mellitus, Type 2
1
2002
1944
0.090
 Why?
Patient Safety
1
2012
303
0.090
 Why?
Promoter Regions, Genetic
1
2013
1230
0.090
 Why?
Cholesterol
2
2007
374
0.090
 Why?
Chromatography, High Pressure Liquid
1
2010
545
0.090
 Why?
Gene Frequency
1
2009
429
0.090
 Why?
Hepatitis A Virus Cellular Receptor 1
2
2018
39
0.090
 Why?
Antithyroid Agents
1
2007
10
0.090
 Why?
Steroids
1
2008
133
0.090
 Why?
Gene Expression
3
2021
1529
0.090
 Why?
Statistics, Nonparametric
1
2009
459
0.090
 Why?
Apolipoprotein A-I
1
2007
26
0.090
 Why?
Apolipoproteins B
1
2007
56
0.090
 Why?
Parathyroidectomy
1
2007
6
0.090
 Why?
Renal Insufficiency
1
2009
125
0.090
 Why?
Canada
1
2008
321
0.090
 Why?
Ergocalciferols
1
2007
14
0.090
 Why?
Lipoprotein(a)
1
2007
44
0.090
 Why?
Kidney Tubules, Distal
1
2007
2
0.090
 Why?
Chronic Kidney Disease-Mineral and Bone Disorder
1
2007
13
0.080
 Why?
Ferrous Compounds
1
2007
26
0.080
 Why?
Pharmacy
1
2007
33
0.080
 Why?
Linear Models
1
2010
884
0.080
 Why?
Aged, 80 and over
3
2017
6818
0.080
 Why?
Calcitriol
1
2007
52
0.080
 Why?
Fibrinogen
1
2007
158
0.080
 Why?
Polysaccharides
1
2007
80
0.080
 Why?
Child, Preschool
3
2011
9618
0.080
 Why?
History, 21st Century
1
2007
198
0.080
 Why?
Staining and Labeling
1
2007
168
0.080
 Why?
Drug Costs
1
2007
96
0.080
 Why?
Health Knowledge, Attitudes, Practice
1
1995
1242
0.080
 Why?
History, 20th Century
1
2007
309
0.080
 Why?
Phosphorus Metabolism Disorders
1
2005
2
0.070
 Why?
Social Behavior
1
2009
331
0.070
 Why?
Diabetes Mellitus, Type 1
1
2002
3136
0.070
 Why?
Role
1
2005
33
0.070
 Why?
Professional Role
1
2007
162
0.070
 Why?
Hypertension
2
2005
1184
0.070
 Why?
Iron
1
2007
230
0.070
 Why?
Coloring Agents
1
2005
78
0.070
 Why?
Propylamines
1
2004
15
0.070
 Why?
Phenethylamines
1
2004
24
0.070
 Why?
Bone Diseases, Metabolic
1
2005
59
0.070
 Why?
Program Development
1
2007
367
0.070
 Why?
Angiotensin-Converting Enzyme Inhibitors
2
2011
227
0.070
 Why?
Safety
2
2004
327
0.070
 Why?
Cost-Benefit Analysis
1
2007
553
0.070
 Why?
Hyperlipidemias
1
2005
141
0.070
 Why?
Phenotype
2
2010
2842
0.070
 Why?
Hyperparathyroidism
1
2003
10
0.070
 Why?
Peritoneal Dialysis, Continuous Ambulatory
1
2003
17
0.070
 Why?
Interdisciplinary Communication
1
2005
204
0.070
 Why?
Time Factors
3
2008
7011
0.060
 Why?
Brain
1
2016
2711
0.060
 Why?
Nausea
1
2003
118
0.060
 Why?
Comorbidity
2
2005
1631
0.060
 Why?
Diabetes Complications
1
2005
234
0.060
 Why?
Guidelines as Topic
1
2005
288
0.060
 Why?
Cell Membrane
1
2007
755
0.060
 Why?
Feasibility Studies
1
2005
747
0.060
 Why?
Calbindins
1
2022
4
0.060
 Why?
Recurrence
1
2005
975
0.060
 Why?
Sex Factors
1
2009
1961
0.060
 Why?
Immunohistochemistry
1
2007
1763
0.060
 Why?
Double-Blind Method
2
2004
1670
0.060
 Why?
Rats
2
2018
6203
0.060
 Why?
Sleep
1
2009
727
0.060
 Why?
Drug Eruptions
1
2002
26
0.060
 Why?
Serotonin 5-HT3 Receptor Antagonists
1
2021
1
0.060
 Why?
Madin Darby Canine Kidney Cells
1
2021
15
0.060
 Why?
United States
2
2008
12446
0.060
 Why?
Cell Line
2
2021
2930
0.060
 Why?
Retrospective Studies
1
2017
11544
0.050
 Why?
Signal Transduction
1
2015
4887
0.050
 Why?
Clinical Trials as Topic
1
2006
1005
0.050
 Why?
Mice, Inbred C57BL
2
2022
5143
0.050
 Why?
Ceftazidime
1
2000
6
0.050
 Why?
Ceftriaxone
1
2000
20
0.050
 Why?
Blood Urea Nitrogen
1
2020
61
0.050
 Why?
Butadienes
1
2020
36
0.050
 Why?
Disease Progression
2
2005
2476
0.050
 Why?
Dogs
1
2021
432
0.050
 Why?
Calcium, Dietary
1
2000
50
0.050
 Why?
Molecular Structure
1
2021
495
0.050
 Why?
Pyrimidinones
1
2020
95
0.050
 Why?
Logistic Models
1
2005
2051
0.050
 Why?
Quality of Health Care
1
2005
647
0.050
 Why?
Nitriles
1
2020
163
0.050
 Why?
Pyridones
1
2020
113
0.050
 Why?
Absorptiometry, Photon
1
2000
242
0.050
 Why?
Tumor Burden
1
2020
287
0.050
 Why?
Acrylonitrile
1
1998
3
0.050
 Why?
Biological Availability
1
2018
146
0.050
 Why?
Cohort Studies
1
2009
4993
0.050
 Why?
Tissue Inhibitor of Metalloproteinase-2
1
2018
11
0.050
 Why?
Polymethyl Methacrylate
1
1998
22
0.050
 Why?
Insulin-Like Growth Factor Binding Proteins
1
2018
22
0.050
 Why?
Prevalence
1
2005
2392
0.050
 Why?
Incidence
1
2005
2449
0.050
 Why?
Acrylic Resins
1
1998
39
0.040
 Why?
Urea
1
1998
86
0.040
 Why?
MAP Kinase Signaling System
1
2020
317
0.040
 Why?
Sulfones
1
1998
104
0.040
 Why?
Rats, Wistar
1
2018
414
0.040
 Why?
Cardiotonic Agents
1
2018
140
0.040
 Why?
Thoracic Surgery
1
2018
123
0.040
 Why?
ROC Curve
1
2018
494
0.040
 Why?
Drug Monitoring
1
1998
190
0.040
 Why?
Surveys and Questionnaires
1
2009
4711
0.040
 Why?
Diabetic Nephropathies
1
2000
276
0.040
 Why?
Neoplasm Proteins
1
2020
433
0.040
 Why?
Bone Density
1
2000
403
0.040
 Why?
Complement C5b
1
2015
4
0.040
 Why?
Cardiovascular Diseases
1
2007
1670
0.040
 Why?
Pennsylvania
1
1995
115
0.040
 Why?
Sulfoxides
1
2015
6
0.040
 Why?
Kelch-Like ECH-Associated Protein 1
1
2015
7
0.040
 Why?
Isothiocyanates
1
2015
6
0.040
 Why?
Risk Factors
3
2012
9036
0.040
 Why?
Protein Transport
1
2017
446
0.040
 Why?
Acute Disease
1
1998
989
0.040
 Why?
Active Transport, Cell Nucleus
1
2015
129
0.030
 Why?
Mental Recall
1
1995
204
0.030
 Why?
Hep G2 Cells
1
2013
77
0.030
 Why?
Polymers
1
1998
479
0.030
 Why?
Real-Time Polymerase Chain Reaction
1
2015
351
0.030
 Why?
Intestinal Mucosa
1
2018
518
0.030
 Why?
Vasodilator Agents
1
2016
336
0.030
 Why?
Glucose
1
2018
893
0.030
 Why?
Organ Specificity
1
2013
299
0.030
 Why?
Exons
1
2013
306
0.030
 Why?
Carrier Proteins
1
2017
814
0.030
 Why?
Cell Proliferation
1
2020
2362
0.030
 Why?
Genetic Variation
1
2017
824
0.030
 Why?
Infant
2
2018
8065
0.030
 Why?
Cell Nucleus
1
2015
615
0.030
 Why?
Insulin
1
2002
2132
0.030
 Why?
Medication Errors
1
2012
97
0.030
 Why?
Lisinopril
1
2011
20
0.030
 Why?
Patient Compliance
1
1995
605
0.030
 Why?
Diagnostic Errors
1
2012
158
0.030
 Why?
Terminology as Topic
1
2012
206
0.030
 Why?
Practice Guidelines as Topic
2
2012
1525
0.030
 Why?
Limit of Detection
1
2009
53
0.030
 Why?
Patient Education as Topic
1
1995
738
0.030
 Why?
Liver Neoplasms
1
2013
457
0.020
 Why?
Apoptosis
1
2020
2609
0.020
 Why?
Calibration
1
2009
139
0.020
 Why?
Quality Control
1
2009
166
0.020
 Why?
Reference Standards
1
2009
193
0.020
 Why?
Drug Stability
1
2009
233
0.020
 Why?
Drug Therapy, Combination
1
2011
1011
0.020
 Why?
Guideline Adherence
1
2012
540
0.020
 Why?
Infant, Newborn
1
2018
5014
0.020
 Why?
Lung Neoplasms
1
2020
2169
0.020
 Why?
Predictive Value of Tests
1
2012
1997
0.020
 Why?
Mutation
1
2017
3403
0.020
 Why?
Expert Testimony
1
2005
54
0.020
 Why?
Clinical Competence
1
2012
917
0.020
 Why?
Drug Tolerance
1
2004
150
0.020
 Why?
Algorithms
1
2011
1514
0.020
 Why?
Receptors, Calcium-Sensing
1
2003
7
0.020
 Why?
Hypercalcemia
1
2003
23
0.020
 Why?
Triglycerides
1
2005
534
0.010
 Why?
Risk Assessment
1
2012
3177
0.010
 Why?
Receptors, Cell Surface
1
2003
395
0.010
 Why?
Injections, Intravenous
1
2000
242
0.010
 Why?
Albuminuria
1
2000
181
0.010
 Why?
Joy's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (391) concept(s)
_
Co-Authors Expand Description
See all (21) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2022 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)